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A traditional Japanese herbal (Kampo) medicine, Hochuekkito (Bu-Zhong-Yi-Qi-Tang in Chinese, TJ-41) is a well-known Kampo
formula, and has been found to enhance antigen-speciﬁc antibody response in not only local mucosal immune system in
upper respiratory tract, but also systemic immune system through upper respiratory mucosal immune system. Although this
immunopharmacologicaleﬀecthasbeenproposedtoexpressbymodulationofintestinalimmunesystemincludingPeyer’spatches
and intestinal epithelial cells, active ingredients are not known. TJ-41 directly aﬀected the production of bone marrow cell-
proliferative growth factors from murine Peyer’s patch immunocompetent cells in vitro. Among low molecular, intermediate size
and macromolecular weight fractions prepared from TJ-41, only fraction containing macromolecular weight ingredients showed
Peyer’s patch-mediated bone marrow cell-proliferation enhancing activity. Anion-exchange chromatography and gel ﬁltration
gave 17 subfractions comprising polysaccharides and lignins from the macromolecular weight fraction of TJ-41, and some of the
subfractions showed signiﬁcant enhancing activities having diﬀerent degrees. Some of the subfractions also expressed stimulating
activity on G-CSF-production from colonic epithelial cells, and statistically signiﬁcant positive correlation was observed among
enhancingactivitiesofthesubfractionsagainstPeyer’spatchimmunocompetentcellsandepithelialcells.Amongthefractionsfrom
TJ-41 oral administration of macromolecular weight ingredient fraction to mice succeeded to enhance antigen-speciﬁc antibody
response in systemic immune system through upper respiratory mucosal immune system, but all the separated fractions failed to
enhance the in vivo antibody response in upper respiratory tract.
1.Introduction
A formula of traditional Japanese herbal (Kampo) medicine,
Hochuekkito (Bu-Zong-Yi-Qi-Tang in Chinese, TJ-41) com-
prises 10 kinds of single herbs, and has been used tradition-
ally for the treatment of weak patients, who have chronic
diseases possessing symptoms such as loss of appetite, mild
fever, night sweat, palpitation, fear, restlessness, weak feeble
voice, slurred speech and disturbance of vision [1]. The
medicine is intended to be applied for patients bearing the
symptoms in respiratory apparatus [2], and given clinical
eﬃcacies for treatments of chronic cold, prevention of
respiratory infection with MRSA on patient having impaired
consciousness [3], prevention of respiratory infection after
surgery [4], and improvement of chronic obstructive pul-
monary disease (COPD) [5, 6] on modern medical care in
Japan.
In upper respiratory tract, speciﬁed local mucosal
immune system exists, and nasal immunization with antigen
induces antigen-speciﬁc plasmablasts in nasal-associated
lymphoreticulartissue(NALT)[7].Theplasmablastsmigrate
into systemic blood stream through jugular lymphatic trunk,2 Evidence-Based Complementary and Alternative Medicine
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Figure 1: Chemical proﬁle of TJ-41 analyzed by 3D HPLC. Each peak of TJ-41 in the HPLC proﬁle was identiﬁed by comparison of the
retention times and UV spectra of chemically deﬁned standard compounds. HPLC condition was as follows: Column; Tosoh TSK GEL ODS-
80Ts (4.6×250mm). Carrier A: 0.05M ammonium acetate (pH 3.6). Carrier B: acetonitrile. Gradient: 10%–100% carrier B linear in 60min.
Flow rate: 1.0mLmin−1. Injection volume: 30 micro liter. Detector: Shimadzu SPD-M10A VP.
and are mainly distributed into spleen and peripheral
lymph nodes as systemic immune system in addition to
laminapropriaofupperrespiratorymucosalimmunesystem
due to interaction between several homing receptors and
their ligands for lymphocytes [7–9]. Finally, antigen-speciﬁc
antibody forming (plasma) cells are produced in these
local immune systems [7, 8] .R e c e n t l y ,w eh a v ef o u n d
that TJ-41 enhances not only antigen-speciﬁc secretory IgA
antibody production in upper respiratory mucosal immune
system, but also antigen-speciﬁc immunoglobulin (IgG)
production in systemic immune system against nasal immu-
nization with antigen [10]. This immunopharmacological
eﬀect of TJ-41 was abrogated by impairment of intestinal
immune system by oral administration of methotrexate [10].
Intestinal mucosal immune system includes Peyer’s patches
and isolated lymphoid follicles (ILF) as the specialized
secondary lymphoid organs [7]. These lymphoid organs
play as inductive sites for mucosal immune system, and
B and T lymphocytes migrate from the organs through
mesenteric lymph node and thoracic duct to the other
local mucosal immune system including upper respiratory
mucosal immune system and systemic immune system [7,
11]. Matsumoto et al. [12] have found that TJ-41 also
enhances antigen-speciﬁc antibody response against oral
immunization in not only intestine but also serum and
nasal cavity. It also has been clariﬁed that proportion
of CD62L-positive B lymphocytes in Peyer’s patches and
blood stream signiﬁcantly increased by oral administration
o fT J - 4 1t om i c e[ 12]. These facts postulates that active
ingredient(s) in TJ-41 interact with immunocompetent cells
in Peyer’s patches to modulate homing receptor expression
and/or cytokine production, resulting in the stimulation of
upper respiratory mucosal immune system through certain
bystander eﬀects of lymphocytes that are recruited from
intestinal immune system. Therefore, it is believed that
Peyer’s patches are one of ﬁrst target organs for expression
of stimulating activity of TJ-41 on upper respiratory and
intestinal mucosal immune systems.
Meanwhile, intestinal lumen are covered by numerous
epithelial cells, and the cells also have been clariﬁed to
play roles as inductive site of mucosal immune system
through expressions of MHC class I and II, some adhesive
molecules like VCAM-1, and several cytokines to crosstalk
with underlying lymphocytes and dendritic cells in laminaEvidence-Based Complementary and Alternative Medicine 3
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Figure 2: Comparison of immunomodulating activities of TJ-41
and TJ-48 against Peyer’s patch immunocompetent cells. Peyer’s
patch cells from early aged C3H/HeJ mice (6-months old) were
cultured in 96-well culture plate with 10, 100, or 200μgmL
−1 of
TJ-41 or TJ-48 for 6 days, and then bone marrow cells from young
C3H/HeJmicewerefurtherculturedwiththeculturesupernatantof
Peyer’s patch cells. Relative amounts of hemopoietic growth factor
in the culture supernatants of Peyer’s patch cells were estimated as
number of proliferated bone marrow cells, which were measured
by Alamar Blue method. Data were expressed as mean ± SD (n =
4), and analyzed by ANOVA followed by post hoc analysis using
Scheﬀe’s test. ALR-5IIa-1-1 is a ß-d-(1→3,6)-galactan-containing
polysaccharide as positive control described previously [17].
propria [13, 14]. Dendritic cells in lamina propria migrate
into mesenteric lymph nodes, and the resulting cells interact
with both lymphocytes and dendritic cells that are recruited
from Peyer’s patches, then lymphocytes in mesenteric lymph
nodes are circulated to populate mucosal and systemic
immune systems through thoracic duct [11, 15]. TJ-41 has
been shown to enhance G-CSF production of both murine
normal colonic epithelial cell-line (MCE301) and primary-
cultured murine colonic epithelial cells [16]. Therefore, it
is hypothesized that active ingredients in TJ-41 interact
with both epithelial cells and immunocompetent cells in
Peyer’s patches, and resulting to potentiate distal mucosal
and systemic immune systems by migration of functionally
modulated lymphocytes through mesenteric lymph nodes
from Peyer’s patches. Although it has been proposed
that macromolecular weight ingredients may contribute to
expression of G-CSF production enhancing activity against
epithelial cells [16], the active ingredients in TJ-41 for
modulation of Peyer’s patch immunocompetent cells are not
known.
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Figure 3: Immunomodulating activity against Peyer’s patch
immunocompetent cells of fractions prepared from TJ-41. Peyer’s
patch cells from early aged C3H/HeJ mice (6 months old) were
cultured in 96-well culture plate with 10, 100 or 200μgmL
−1 of
TJ-41 or its fractions for 6 days, and then bone marrow cells
from young C3H/HeJ mice were further cultured with the culture
supernatant of Peyer’s patch cells. Relative amounts of hemopoietic
growth factor in the culture supernatants of Peyer’s patch cells
were estimated as number of proliferated bone marrow cells, which
were measured by Alamar Blue method. Data were expressed as
mean ± SD (n = 4), and analyzed by ANOVA followed by post
hoc analysis using Scheﬀe’s test. ALR-5IIa-1-1 is a ß-d-(1→3,6)-
galactan-containing polysaccharide as positive control described
previously [17].
This article deals with clariﬁcation of active ingredients
in TJ-41 for modulation of immunocompetent cells in
Peyer’spatches,andpolysaccahride-containingmacromolec-
ular ingredients in TJ-41 were found to be dual active
ingredients for Peyer’s patch cells and intestinal epithelial
cells.
2. Methods
2.1. Materials. Spray-dried extract preparation of Ho-
chuekkito (Bu-Zhong-Yi-Qi-Tang in Chinese, TJ-41, batch
no. 920041001PO) was kindly supplied from Tsumura &
Co. (Tokyo, Japan). For the preparation of TJ-41, a mixture
of Astragali Radix (4g, roots of Astragalus membranaceus
Bunge), Atractylodis lanceae Rhizoma (4g, rhizomes of
Atractylodes lancea DC.), Ginseng Radix (4g, roots of
Panax ginseng C.A. Meyer), Angelicae Radix (3g, roots4 Evidence-Based Complementary and Alternative Medicine
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Figure 4: Eﬀect of chemical and enzymic treatments of F-2 (a) and F-5 (b) on the immunomodulating activity against Peyer’s patch
immunocompetent cells of F-2 and F-5. Peyer’s patch cells from early aged C3H/HeJ mice (6 months old) were cultured in 96-well culture
plate with 50 or 100μgmL
−1 of periodate, chlorite or amylase treated F-2 (a) or F-5 (b) for 6 days, and then bone marrow cells from young
C3H/HeJ mice (7 weeks old) were further cultured with the culture supernatant of Peyer’s patch cells. Relative amounts of hemopoietic
growth factor in the culture supernatants of Peye’s patch cells were estimated as number of proliferated bone marrow cells, which were
measured by Alamar Blue method. Data were expressed as mean ± SD (n = 4), and analyzed by ANOVA followed by post hoc analysis using
Scheﬀe’s test. ALR-5IIa-1-1 is a ß-d-(1→3,6)-galactan-containing polysaccharide as positive control described previously [17].
Table 1: Chemical properties of F-2 and F-5 and their chemical and enzymatic treated products.
F-2 F-2 Amylase
digested
F-2 Periodate
oxidized
F-2 Chlorite
treated
F-5 F-5 Amylase
digested
F-5 Periodate
oxidized
F-5 Chlorite
treated
Carbohydrate
content (%)
65.2 36.5 19.2 101.8 105.3 62.7 37.9 102.8
Uronic acid
content (%)
7.3 14.4 3.6 8.2 19.2 29.9 4.2 20.3
Protein content
(%)
4.1 10.8 26.4 11.6 7.5 15.6 13.4 14.0
Component
sugar (mol.%)
Arabinose 3.4 9.9 n.d.a 2.2 10.8 16.3 11.6 6.8
Rhamnose 0.5 1.4 n.d. 0.3 2.1 1.8 3.0 0.9
Fucose 0.1 0.6 n.d. 0.1 0.3 0.3 n.d. 0.2
Xylose 1.0 1.8 n.d. 0.8 0.9 1.8 2.5 1.3
Glucuronic acid 0.6 trace trace trace 0.5 trace trace trace
Galacturonic
acid
5.5 48.0 70.4 10.7 18.0 63.0 46.3 30.4
Mannose trace 5.0 3.2 1.1 trace 1.7 race trace
Galactose 2.1 12.6 13.1 4.8 6.2 9.4 29.9 4.3
Glucose 86.9 20.9 13.4 80.0 61.4 5.7 6.6 56.1
aNot detected.Evidence-Based Complementary and Alternative Medicine 5
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Figure 5: Elution pattern in anion-exchange chromatography of F-
5 on DEAE-Sepharose. F-5 was applied to a DEAE-Sepharose FF
column (HCO3
−form), and the neutral fraction (F-5I) was eluted
with water. Eight absorbed fractions were gradually eluted from the
columnwithincreasedconcentrationsofHCO3
− solutionasshown
in this ﬁgure by stepwise manner. The eluted respective fractions
were monitored for carbohydrate by phenol-sulfuric acid method
(490nm),uronicacidbym-hydroxybiphenylmethod(520nm)and
phenolics or proteins by ultraviolet absorption at 280nm.
of Angelica acutiloba Kitagawa), Bupleuri Radix (2g, roots
of Bupleurum falcatum L.), Zizyphi Fructus (2g, fruits of
Zizyphus jujuba Miller var. inermis Rehder), Aurantii Bobilis
Pericarpium (2g, pericarps of ripe fruits of Citrus unshu
Markovich), Glycyrrhizae Radix (1.5g, roots of Glycyrrhiza
uralensis Fisch et DC.), Cimicifugae Rhizoma (1g, rhizomes
of Cimicifuga simplex Wormskjord) and Zingiberis Rhizoma
(0.5g, rhizomes of Zingiber oﬃcinale Roscoe) was extracted
with 285mL of water by heating at 100◦Cf o r1 h .T h e
extracted solution was ﬁltered and spray-dried to obtain
dry extract powder (TJ-41, 5g). Three-dimensional high
performance liquid chromatography (HPLC) analysis was
carried out to know chemical proﬁle of TJ-41, and the spray-
dried extract preparation of TJ-41 showing 3D-HPLC proﬁle
as in Figure 1 was used for the present study. Spray-dried
extract preparation of Juzentaihoto (Shi-Quan-Da-Bu-Tang,
TJ-48, batch no. 890048001PO) was also kindly supplied
from Tsumura & Co. as described previously [10]. Arabino-
3,6-galactan (ALR-5IIa-1-1), which has immunomodulating
activity against Peyer’s patch cells, was puriﬁed as a positive
control from rhizomes of Atractylodeslanceaaccordingtothe
procedure of Yu et al. [17].
2.2. Cells. Establishment and characterization of murine
normal colonic epithelial cell-line MCE301 were reported
previously [18]. The MCE301 cells were cultured according
to the procedure of Matsumoto et al. [16].
2.3. Animals. Speciﬁc pathogen-free female C3H/HeJ and
BALB/c mice of 7 weeks old (young) and 6 months old
(early aged) were purchased from Japan SLC (Shizuoka,
Japan). The animals were housed in plastic gages in an air-
conditionedroomat23±2◦Cwitharelativehumidityof55±
10% under a 12-h light-dark cycle, fed a standard laboratory
diet and given water ad libitum. Animal experiments were
approved by the Animal Research Committee of Kitasato
University, and performed in accordance with Guidelines for
Care and Use of Laboratory Animal at Kitasato University
and the National Research Council Guide for the Care and
Use of Laboratory Animals in Japan.
2.4. Analytical Methods. The carbohydrate, uronic acid
and protein contents were determined by phenol—H2SO4
method [19], m-hydroxybiphenyl method [20]a n dB ra d f o r d
method [21], respectively, using galactose, galacturonic acid
and bovine immunoglobulin as the respective standards.
Lignin contents were analyzed by acetyl bromide method
[22]. Component sugars were analyzed as TMS methylglyco-
side derivatives [23] by GC on Hewlett-Packard Model 5890
series II gas chromatograph as described previously [16].
2.5. Fractionation of TJ-41. TJ-41 (100g) was fraction-
ated into ﬁve fractions; MeOH-soluble fraction (F-1, yield
73.3%), MeOH and water-insoluble fraction (F-2, yield
9.9%), dialyzable intermediate size ingredient fraction (F-3,
yield 4.8%) and non-dialyzable intermediate size ingredient
fraction(F-4,yield0.2%),andmacromolecularweightingre-
dient fraction (F-5, yield 7.7%) according to the method
described previously [16].
2.6.PeriodateOxidationofF-2andF-5fromTJ-41. Periodate
oxidation was performed by the procedure as described
previously [16].
2.7. Amylase Digestion of F-2 and F-5 from TJ-41. Amylase
digestion was performed as described previously [16].
2.8. Chlorite Treatment of F-2 and F-5 from TJ-41. Solutions
o fF - 2a n dF - 5( 1ge a c h )i n4 %a c e t i ca c i d( 5 0 0m L )w e r e
each added sodium chlorite (5g), and incubated at 70◦C
for 40min. The reaction mixtures were neutralized with
3M NaOH, and then dialyzed against distilled water for
4 days. The non-dialyzable portions were concentrated by
evaporation, and lyophilized to obtain chlorite-treated F-2
(yield 78.2%) and F-5 (yield 75.5%).
2.9. Puriﬁcation of Polysaccharides and Lignin-Polysaccharide
Complexes from F-5
2.9.1. Anion-Exchange Chromatography. As o l u t i o no fF - 5
(2.6g) in 300mL of distilled water was applied to a DEAE-
Sepharose FF column (HCO3
−), GE Healthcare Japan,
5.5 × 25cm), and a neutral fraction (F-5I, 1.15g, yield from
F-5; 44.5%) was obtained by washing with distilled water.
Absorbed fractions were eluted gradually with 50, 100, 200,
300, 400, 500, 600mM and 1MNH4HCO3 in a stepwise
manner, and each eluate was dialyzed and lyophilized6 Evidence-Based Complementary and Alternative Medicine
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Figure 6: Elution patterns in size exclusion chromatography of fractions obtained from Figure 5 on Sephacryl S-200. F-5IIa (a), F-5IIb
(b), F-5IIc (c), F-5IId (d), F-5IIe (e), F-5IIf (f) and F-5IIh (g) from Figure 5 were applied to a Sephacryl S-200 column equilibrated with
0.2MNaCl, and eluted with the same solution. The eluted respective fractions were monitored for carbohydrate by phenol-sulfuric acid
method (490nm), uronic acid by m-hydroxybiphenyl method (520nm) and phenolics or proteins by ultraviolet absorption at 280nm.
to obtain eight fractions; F-5IIa (50mMNH4HCO3, 210mg,
y i e l df r o mF - 5 ;8 . 1 % ) ,F - 5 I I b( 1 0 0m MN H 4HCO3,5 6 m g ,
2.2%), F-5IIc (200mMNH4HCO3, 249mg, 9.6%), F-5IId
(300mMNH4HCO3, 97.3mg, 3.8%), F-5IIe (400mM
NH4HCO3, 478mg, 18.5%), F-5IIf (500mMNH4HCO3,
38mg, 1.5%), F-5IIg (600mMNH4HCO3,6m g ,0 . 2 % ) ,a n d
F-5IIh (1MNH4HCO3, 19mg, 0.7%).
2.9.2. Gel Filtration. All acidic fractions, obtained from F-5
by anion-exchange chromatography except F-5IIg (because
of too small amount available), were individually fraction-
ated on a Sephacryl S-200 column (2.6 × 93cm) with
0.2MNaCl. All the resulting subfractions were dialyzed
against distilled water, and lyophilized to give 17 diﬀerent
polysaccharide-containing fractions (PS1–PS17).
2.10. Measurement of In Vitro Immunomodulating Activity
against Peyer’s Patch Immunocompetent Cells. Immunomod-
ulating activity was measured by enhanced production of
bone marrow cells-proliferative cytokines from Peyer’s patchEvidence-Based Complementary and Alternative Medicine 7
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Figure 7: Immunomodulating activities against Peyer’s patch immunocompetent cells and intestinal epithelial cells of polysaccharide-
containing subfractions obtained from macromolecular weight ingredient fraction (F-5) of TJ-41. (a) Immunomodulating activities against
Peyer’s patch immunocompetent cells of the subfractions obtained from Figure 6. Peyer’s patch cells from early aged C3H/HeJ mice (6
months old) were cultured in 96-well culture plate with 100μgmL
−1 of the subfractions for 6 days, and then bone marrow cells from young
C3H/HeJ mice (7 weeks old) were further cultured with the culture supernatant of Peyer’s patch cells. Relative amounts of hemopoietic
growth factor in the culture supernatants of Peyer’s patch cells were estimated as number of proliferated bone marrow cells, which were
measured by Alamar Blue method. (b) IL-6 production enhancing activity on Peyer’s patch immunocompetent cells of the subfractions
from Figure 6. Peyer’s patch cells from early aged C3H/HeJ mice (6 months old) were cultured in 96-well culture plate with 100μgmL
−1 of
the subfractions for 6 days, and IL-6 content in the culture supernatant was measured using an ELISA. (c) G-CSF production enhancing
activity on intestinal epithelial cells of the subfractions from Figure 6. Murine colonic epithelial cell line, MCE301 cells were cultured for 48h
in 96-well culture plate with 0.5μgmL
−1 of the subfractions, and G-CSF content in the culture supernatant was measured using an ELISA.
All data were expressed as mean ± SD (n = 4), and analyzed by ANOVA followed by post hoc analysis using Scheﬀe’s test.
cells of 7 weeks old female C3H/HeJ mice according to Hong
et al. [24].
2.11. Measurement of G-CSF Production Enhancing Activity
on MCE301 Cells. The procedure was performed in accor-
dance with the method described previously [16].
2.12. Measurement of In Vivo Immunomodulating Activity of
Fractions from TJ-41 on Upper Respiratory Mucosal Immune
System. The procedures were carried out according to the
method described previously [10]. Brieﬂy, young or early
agedBALB/cmicewereimmunizedtwicewithaprimaryand
secondary intranasal inoculations of 5μg of a split vaccine
of inﬂuenza hemagglutinin (inﬂuenza A/NC/20 HA vaccine)
(kind gift from Center for Biologicals of The Kitasato Insti-
tute) at Days 0 and 28. The mice were administered orally
aqueous solutions of TJ-41 (100mgkg−1 day−1)o re a c h
fraction (F-1 (73.3mgkg−1 day−1), F-2 (9.9mgkg−1 day−1),
F-3 (4.8mgkg−1 day−1), F-4 (0.2mgkg−1 day−1)a n dF - 5
(7.7mgkg−1 day−1)) (doses were calculated by the yields of
the respective fractions from TJ-41) from 7 days before the
primary immunization (Day-7) to Day 42 once a day. The
serawerepreparedfrombloodsamplesofthemiceatDay42,
andthennasalwashesweretakenfromtheposterior opening
of the nasopharynx by injection with sterilized phosphate
buﬀered saline containing 0.1% bovine serum albumin. The
titers of inﬂuenza virus-speciﬁc IgG antibody (in sera) and
IgA antibody (in nasal washes) were measured by ELISA
according to the procedure as described previously [10].
2.13. Statistics. Data were expressed as mean ± SD, and
diﬀerences between groups were analyzed by analysis of
variance (ANOVA) followed by post hoc analyses using
Scheﬀe’s test. The probability (P)v a l u e s< .05 were consid-
ered signiﬁcant.8 Evidence-Based Complementary and Alternative Medicine
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Figure 8: Positive signiﬁcant correlation between degrees of
immunomodulating activity against Peyer’s patch immunocompe-
tent cells and G-CSF production enhancing activity on intestinal
epithelial cells of polysaccharide-containing subfractions in TJ-
41. Two-dimensional scatter plot was made from the data of
immunomodulating activity against Peyer’s patch immunocompe-
tent cells and G-CSF production enhancing activity on MCE301
cells of 17 subfractions obtained from Figure 6. Regression line
was calculated by least squares method, and estimated Pearson’s
correlation coeﬃcient (γ).
3. Results
3.1. Evaluation of Immunomodulating Activity of TJ-41
against Peyer’s Patch Immunocompetent Cells. In order to
analyze whether TJ-41 is able to modulate directly functions
of immunocompetent cells in Peyer’s patches, after Peyer’s
patch cells from early aged (6 months old) C3H/HeJ mice
were cultured with TJ-41 for 6 days, bone marrow cells from
young (7 weeks old) C3H/HeJ mice were further cultured
with the culture supernatant of Peyer’s patch cells, and
then relative amounts of hemopoietic growth factors in the
culture supernatant produced from Peyer’s patch cells were
estimated as number of the proliferated bone marrow cells.
The numbers of proliferated bone marrow cells signiﬁcantly
increased when Peyer’s patch cells were cultured with TJ-41
(Figure 2).Thedegreeof theenhancementwassameasthose
whenPeyer’spatchcellswereculturedwithJuzentaihoto(TJ-
48), which has been reported to have immunomodulating
activity against Peyer’s patch cells [24]( Figure 2).
3.2. Analysis of Active Ingredients for Immunomodulation of
Peyer’s Patch Immunocompetent Cells. In order to elucidate
which ingredient in TJ-41 contributes to expression of
immunomodulating activity against Peyer’s patch immuno-
competent cells, TJ-41 was roughly fractionated by MeOH
extraction, water extraction, EtOH precipitation and dialysis
to obtain MeOH-soluble fraction (F-1), MeOH- and water-
insoluble fraction (F-2), MeOH-insoluble and dialyzable
fraction as dialyzable intermediate size ingredient fraction
(F-3), EtOH-soluble and non-dialyzable fraction as non-
dialyzable intermediate size ingredient fraction (F-4), and
macromolecularweightingredientfraction(F-5)[16].When
theseﬁvefractionsweretestedforimmunomodulatingactiv-
ityagainstPeyer’spatchcells,F-2andF-5showedstatistically
signiﬁcant activity, but not the other fractions (Figure 3).
Both F-2 and F-5 consisted mainly of carbohydrate (Table 1),
and periodate oxidation, which is capable to degrade carbo-
hydrate moieties, signiﬁcantly decreased activities of both F-
2a n dF - 5( Figure 4). Because F-2 and F-5 mainly comprised
g l u c o s ea sac o m p o n e n ts u g a r( Table 1), suggesting the
presence of starch-like polysaccharide in these fractions,
both fractions were also digested with α-a n dβ-amylases.
Amylase digestion did not reduce activities of both F-2 and
F-5 (Figure 4). Component sugar analyses indicated that the
amylase-digested F-2 and F-5 reduced contents of glucose
signiﬁcantly, and consisted mainly of galacturonic acid in
addition to notable proportions of arabinose and galactose
(Table 1). When F-2 and F-5 each were treated with sodium
chlorite in order to destroy lignin molecules, the reaction
products reduced the activity, but the considerable activity
still remained for both F-2 and F-5 (Figure 4). These results
suggested that F-2 and F-5 contained polysaccharides and/or
lignin-polysaccharide complexes as active ingredients, and
it was assumed that these active macromolecules in TJ-
41 were separately fractionated into F-2 (water-insoluble
fraction)andF-5(water-solublefraction)dependingontheir
solubility in water.
F-5 was further fractionated by anion-exchange chro-
matography on a DEAE-Sepharose FF column (HCO
−
3 )
and one neutral (F-5I) and 8 acidic fractions (F-5IIa–F-
5IIh) were obtained (Figure 5). All acidic fractions con-
sisted of arabinose, galactose, glucose and/or galacturonic
acid whereas the neutral fraction (F-5I) mainly comprised
glucose (data not shown). Although F-5I did not show
immunomodulating activity against Peyer’s patch cells, all
acidic fractions had signiﬁcant activity (data not shown).
Therefore, the acidic fractions were further fractionated by
gel ﬁltration except F-5IIg because of too small amount
available. By gel ﬁltration on a Sephacryl S-200 column,
F-5IIa, IIc, IId, and IIf each gave two subfractions (PS1
and PS2 (from F5-IIa), PS6 and PS7 (from F-5IIc), PS8
and PS9 (from F-5IId), and PS13 and PS14 (from F-5IIf)),
which were rich in carbohydrate (Figure 6). Whereas, F-
5IIb, IIe and IIh gave three carbohydrate-rich subfractions
each (PS3, PS4, and PS5 (from F-5IIb), PS10, PS11, and
PS12 (from F-5IIe), and PS15, PS16, and PS17 (from F-
5IIh)). Analyses of chemical properties indicated that PS1,
PS2, PS3, PS4, PS5, PS11, PS12, and PS13 consisted mainly
(over 80%) of carbohydrate (total of carbohydrate and
uronic acid contents in Table 2), whereas PS7, PS8, PS9,
PS10, and PS14 comprised about 60–70% of carbohydrate
(Table 2). Meanwhile, PS6, PS15, PS16, and PS17 contained
<60% of carbohydrate. All subfractions contained diﬀerent
amount of lignin, especially, PS9, PS12, PS14, PS16 and
PS17 were composed of over 20% of lignin (Table 2).
When these subfractions were analyzed immunomodulating
activity against Peyer’s patch cells, PS5, PS6, PS9, PS12,
PS13, PS14, PS15, PS16 and PS17 showed the signiﬁcant
activity, and the other subfractions seemed to have weak
activity except PS10 although statistical signiﬁcances were
not be observed (Figure 7(a)). Because TJ-41 up-regulated10 Evidence-Based Complementary and Alternative Medicine
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Figure 9: Eﬀect of oral administration of TJ-41 or its fractions on antibody responses in systemic immune system and upper respiratory
mucosal immune system against nasal immunization. (a) Enhancing activity on inﬂuenza virus-speciﬁc IgG antibody response in systemic
immune system against nasal immunization in young mice. Young BALB/c mice (7 weeks old) were intranasally immunized twice with
inﬂuenza vaccine, and TJ-41 (100mgkg−1 day−1) or its subfractions (each daily dose was calculated to be equivalent to 100mgkg−1 day−1 of
TJ-41 from the yield of each fraction) were orally administered to the immunized mice. Sera were taken from the mice, and antiinﬂuenza
virus-speciﬁcIgGantibodytiterintheserawasmeasuredbyELISA.(b)Enhancingactivityoninﬂuenzavirus-speciﬁcIgAantibodyresponse
in nasal cavity against nasal immunization in early aged mice. Early aged BALB/c mice (6 months old) were intranasally immunized twice
with inﬂuenza vaccine, and TJ-41 (100mgkg−1 day−1) or its fractions (each daily dose was calculated to be equivalent to 100mgkg−1 day−1
of TJ-41 from the yield of each fraction) were orally administered to the immunized mice. Nasal washes were taken from the mice, and
anti-inﬂuenza virus-speciﬁc IgA antibody titer in the washes was measured by ELISA. All data were expressed as mean ± SD (n = 8), and
analyzed by ANOVA followed by post hoc analysis using Scheﬀe’s test.
mRNA expression of interleukin-6 (IL-6) on Peyer’s patch
immunocompetent cells (data not shown), the eﬀect of these
subfractions on production of IL-6 from Peyer’s patch cells
were also evaluated. As shown in Figure 7(b), PS6, PS12,
PS13,PS14,PS15,PS16andPS17signiﬁcantlyenhancedIL-6
production from Peyer’s patch cells.
3.3. Evaluation of Modulating Activity of Polysaccharide-
Containing Macromolecules from TJ-41 on G-CSF Production
of Intestinal Epithelial Cells. Previous study has indicated
that TJ-41 enhances de novo G-CSF synthesis on the
murine colonic epithelial cell line, MCE301, and that only
macromolecular weight ingredient fraction (F-5) of TJ-41
has G-CSF production enhancing activity on MCE301 [16].
Therefore, PS1–PS17 obtained from F-5 in the present study
were also analyzed eﬀects on G-CSF production of MCE301.
As shown in Figure 7(c),P S 2 ,P S 5 ,P S 6 ,P S 7 ,P S 1 1a n d
PS12–PS17 signiﬁcantly enhanced G-CSF production at a
concentration of 0.5μgmL
−1. Simple linear regression anal-
ysis was performed between degrees of immunomodulating
activity against Peyer’s patch cells and G-CSF production
enhancing activity on MCE301 cells of these subfractions.
The statistically signiﬁcant positive correlation (γ = 0.68559,
P<. 01, n = 17) between both activities was observed
(Figure 8), and suggesting that these subfractions modulate
functions of not only Peyer’s patch immunocompetent cells
but also intestinal epithelial cells.
3.4. Contribution of Polysaccharide-Containing Macromol-
ecules for Immunomodulating Activity of TJ-41 on Upper
Respiratory Mucosal Immune System. It has been found
that oral administration of TJ-41 stimulates antigen-speciﬁc
antibody production on only systemic immune system
againstnasallyinoculatedantigentotheyoungmice(7weeks
old) [10], whereas TJ-41 enhances antibody production
on upper respiratory tract of early aged mice (6 months
old) [10]. In order to evaluate whether polysaccharide-
containing macromolecules in TJ-41 contribute to expres-
sion of enhancing activity on upper respiratory mucosal
immune system of TJ-41, each of F-1–F-5 obtained from
TJ-41, was orally administered at doses related to their
yields from TJ-41 to young or early aged BALB/c mice,
which were nasally immunized twice with inﬂuenza vaccine,
and titers of inﬂuenza virus speciﬁc IgG or IgA antibodyEvidence-Based Complementary and Alternative Medicine 11
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Figure 10: Hypothetical diagram on responsible ingredients in Hochuekkito (TJ-41) for expression of stimulating activity on antibody
response against intranasal immunization.
were measured for sera or nasal washes from the mice,
respectively. Oral administrations of F-1, F-2, F-3, and F-4
failed to increase inﬂuenza virus speciﬁc IgG antibody titer
in sera of young mice, whereas F-5 signiﬁcantly enhanced
the antibody titer as same as TJ-41 (Figure 9(a)). However,
when these fractions each were administered to early aged
mice, all fractions did not enhance inﬂuenza virus speciﬁc
IgA antibody titer in nasal cavity even though TJ-41 could
(Figure 9(b)).
4. Discussion
In previous study TJ-41 has been found to potentiate anti-
body response in upper respiratory mucosal immune system
in vivo but not another Kampo formula, TJ-48, and it has
been suggested that TJ-41 express this stimulating activity
through intestinal immune system [10]. The present study
indicated that TJ-41 directly modulated immunocompetent
cells in Peyer’s patches to enhance production of bone
marrow cell-proliferative growth factors in vitro.H o w e v e r ,
signiﬁcant diﬀerence could not be observed between TJ-
41 and TJ-48. When mRNA expressions of cytokines were
analyzed by PCR using cells which were cultured with either
TJ-41 or TJ-48 for 6 days, enhanced mRNA expressions
of IL-2, IL-5, IL-6, IL-10 and TGF-β were observed in
cultured Peyer’s patch cells with TJ-41 compared with those
in cells cultured without the formula (Kiyohara & Nonaka,
unpublished data). Meanwhile, TJ-48 signiﬁcantly enhanced
mRNA expression of only IL-2 (Kiyohara & Nonaka,
unpublished data). These results postulated that TJ-41 might
modulatecytokineproductionsindiﬀerentmannerfromTJ-
48. The diﬀerence may bring to one of reasons why TJ-41
can potentiate upper respiratory mucosal immune system.
It is necessary to analyze how TJ-41 and TJ-48 diﬀerently
modulate cytokine production on immunocompetent cells
in Peyer’s patches in vivo in future study.
Numerous ingredients are considered to be present
in TJ-41 because this multiherbal formula consists of 10
kinds of component herbs. The present study indicated that
macromolecular weight ingredients in F-5 were responsible
active ingredients for immunomodulation of Peyer’s patch
immunocompetent cells. All macromolecular weight ingre-
dients in TJ-41 comprised various proportions of polysac-
charides and lignins. Polysaccharides and lignins are pri-
mary metabolites, and lignins are generally conjugated with
poly- and oligosaccharides to form lignin-polysaccharide
complexes in plant cell walls [25, 26]. The present study
suggeststhatbothstructuralmoietiesarerequiredforexpres-
sion of modulating activity on Peyer’s patch cells because
the activity was signiﬁcantly reduced by both periodate
oxidation and chlorite treatment. However, no correlation
was observed between lignin contents and degrees of the
immunomodulating activity on Peyer’s patch cells of 17
subfractions, and it is assumed that detailed structural parts
of both lignin and polysaccharide moieties may participate
to expression of the immunomodulating activity. We have
already found a immunomodulating polysaccharide (ALR-
5IIa-1-1 used as a positive control in the present study)
against Peyer’s patch cells from Atractylodes lancea as one of
component herbs of TJ-41 [17], and this polysaccharide was
shown to express the activity through β-d-(1→3,6)-galactan
moiety as the active carbohydrate sequence [27]. Although
ALR-5IIa-1-1 clearly decreased the activity by an enzy-
matic degradation of β-d-(1→3,6)-galactan moiety [27],12 Evidence-Based Complementary and Alternative Medicine
the immunomodulating activity against Peyer’s patch cells
of some of the fractions obtained from F-5 of TJ-41 could
not be reduced by the same enzymatic degradation for β-d-
(1→3,6)-galactan moiety (Kiyohara & Sekiya, unpublished
data). These results assumed that the active polysaccharides
and lignin-polysaccharide complexes in TJ-41 have diﬀerent
responsible structures from ALR-5IIa-1-1 for expression of
the activity.
Intestinal epithelial cells sit at interface between lumen
and lymphocyte-rich lamina propria. The epithelial cells
function as eﬀector/regulator cells of a host’s immune
response to foreign substances including various pathogens
and food antigens [13, 14]. Matsumoto et al. have suggested
that certain ingredients in F-5 of TJ-41 contribute to express
G-CSF production enhancing activity on intestinal epithelial
cells [16]. A question arises whether Peyer’s patch cells-
modulating polysaccharides and/or lignin-polysaccharide
complexes, isolated from TJ-41 in the present study, also
have enhancing activity on G-CSF production of intesti-
nal epithelial cells. Correlation analysis strongly suggests
that immunomodulating polysaccharides and/or lignin-
polysaccharide complexes against Peyer’s patch cells in TJ-
41 also interact with intestinal epithelial cells to aﬀect on
their immunological functions. This proposes that polysac-
charides and/or lignin–polysaccharide complexes play as
dual active ingredients for immunomodulation of immuno-
competent cells in Peyer’s patches and intestinal epithelial
cells. It has been reported that carbohydrate moiety of
polysaccharide and/or lignin-polysaccharide complexes in F-
5 participate to enhancing activity of G-CSF production of
intestinal epithelial cells [16]. However, structural features
of the responsible carbohydrate moiety in the subfractions
from F-5 also could not be analyzed in the present study,
and further study needs to be carried out for clariﬁcation
of responsible structures for immunomodulation of intesti-
nal epithelial cells and immunocompetent cells in Peyer’s
patches.
Another question arises whether only macromolecular
weight ingredients in TJ-41 behave as responsible molecules
for expression of stimulating activity on upper respira-
tory mucosal immune system of TJ-41. The present study
indicated that oral administration of only polysaccharides
and/or lignin-polysaccharide complexes in F-5 potentiates
antibody response against nasal inoculated antigen in sys-
temic immune system. Antibody response against nasal
immunization in systemic immune system is known to be
induced as a result of migration of antigen-speciﬁc lym-
phocytes from NALT to spleen and peripheral lymph nodes
[7–9]. Parts of naive and activated lymphocytes in Peyer’s
patches are generally considered to migrate into spleen and
peripheral lymph nodes to interact with lymphocytes which
are recruited from NALT [11]. Therefore it is hypothesized
that antigen-speciﬁc antibody productions in spleen and
peripheral lymph nodes may be enhanced by interaction
between lymphocytes from NALT and Peyer’s patch lym-
phocytes which were functionally modulated by the actions
of polysaccharides/lignin-polysaccharide complexes of TJ-
41. Since the possibility that these macromolecular weight
ingredients directly enhance systemic immune system after
their absorption from digestive system is not ruled out,
detailed mechanism for this stimulatory eﬀect is necessary
to investigate by further study.
The present study indicated that not only macromolec-
ular weight ingredients (F-5) but also other ingredients (F-
1, F-2, F-3, and F-4) of TJ-41 could not stimulate antibody
response in upper respiratory tract against nasal immu-
nization unlike TJ-41. This result strongly postulates that
stimulation of upper respiratory mucosal immune system by
the action of TJ-41 may be expressed by contributions of
numerous ingredients in the fractions, F-1 to F-5 of TJ-41. It
is generally known that lymphocytes are recruited to upper
respiratory mucosal immune system from both hemopoietic
system and Peyer’s patches to control the immune system
[7–9]. Process of lymphocyte homing from Peyer’s patches
to upper respiratory mucosal immune system is regulated
by many molecules: (i) adhesive molecules like CD62L (L-
selectin) and integrin a4β1, and chemokine receptors (CCR7
and CCR10) on lymphocytes, (ii) ligands for adhesion
molecules like 6-sulfosialy LewisX-expressing glycoprotein
(PNAd) and VCAM-1, and chemokine like CCL28 on high
endothelial venule (HEV) in upper respiratory tract [7–
9]. It is diﬃcult to consider that macromolecular weight
ingredients of TJ-41 modulate expression of all above
homing-related molecules. Therefore, it is hypothesized that
TJ-41 may contain some other active ingredients, which
can modulate expression of these homing-related molecules
in addition to polysaccharides/lignin-polysaccharides, which
modulate functions of immunocompetent cells in Peyer’s
patches and intestinal epithelial cells (Figure 10). Further
study concerning with clariﬁcation of modulating ingre-
dients on expression of homing-related molecules in TJ-
41 may lead us to understand detailed mechanism for
immunomodulation of upper respiratory mucosal immune
system by the action of TJ-41.
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